Thinzar Min

Views and understanding of metabolic dysfunction-associated steatotic liver disease in patients with diabetes

Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial

Assessing glycaemic impact of FreeStyle libre monitoring in patients with insulin-treated type 2 diabetes: a retrospective real-world analysis

The Use of Non-invasive Biomarkers to Screen for Advanced Fibrosis Associated with Metabolic Dysfunction-associated Steatotic Liver Disease in People with Type 2 Diabetes: A Narrative Review

Perioperative Screening for Metabolic Dysfunction Associated Steatotic Liver Disease in People Undergoing Bariatric Surgery: A Pilot Study

Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study

Metformin Use and Vitamin B12 Deficiency in People with Type 2 Diabetes. What Are the Risk Factors? A Mini-systematic Review

Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in <scp>UK</scp> primary care practice: An expert consensus

The Bidirectional Relationship Between Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study

P330 The real-world impact of treatments for type 2 diabetes on outcomes in people with non-alcoholic fatty liver disease

P323 Routine screening for steatotic liver disease in people with diabetes: a patient survey

P375 The accuracy of non-invasive tests for advanced hepatic fibrosis associated with metabolic dysfunction-associated steatotic liver disease in type 2 diabetes

P351 The impact of increased body mass on non-invasive test accuracy for advanced hepatic fibrosis with metabolic dysfunction-associated steatotic liver disease

A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena

Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trials

Benefits in routinely measured liver function tests following bariatric surgery: a retrospective cohort study

Freestyle libre use in people with type 2 diabetes using basal-bolus insulin is associated with improved glycaemic control: A real-world analysis

Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity

Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?

Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study

Virtual postgraduate medical education: Here to stay?

COVID-19 outcomes in people with diabetes in Wales: a secondary analysis of the ABCD audit

The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials

Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk

The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes

Temporal Effects of Bariatric Surgery on Adipokines, Inflammation and Oxidative Stress in Subjects with Impaired Glucose Homeostasis at 4 Years of Follow-up

Temporal Effects of Sleeve Gastrectomy on Glucose-Insulin Homeostasis and Incretin Hormone Response at 1 and 6 Months

Estimands in diabetes clinical trials

Effect of Laparoscopic Sleeve Gastrectomy on Static and Dynamic Measures of Glucose Homeostasis and Incretin Hormone Response 4-Years Post-Operatively

Temporal effects of laparoscopic sleeve gastrectomy on adipokines, inflammation, and oxidative stress in patients with impaired glucose homeostasis